UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off
Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research.…
22/02/2017 - 2 minutes
GSK
Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to…
14/02/2017 - 2 minutes
Investors Jump on Hypersensitivity Peptides from GSK Spinout
Neurokinins are under investigation for a range of conditions from women's health to pain. NeRRe…
05/01/2017 - 2 minutes
French Biotech Puts a New Lyme Disease Vaccine on the Horizon
There is currently no vaccine for the fast-growing disease in the US, & treatments cost…
12/12/2016 - 2 minutes
UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa
Update (01/12/2016): The HVTN 702 trial has been started, making it the first HIV vaccine…
01/12/2016 - 3 minutes
UPDATE: GSK is staging a comeback with a new Shingles Vaccine
GSK is banishing concerns about its health with a BLA submission for Shingrix, which has…
30/11/2016 - 2 minutes
Results from 45% of Clinical Trials are kept Secret
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…
07/11/2016 - 2 minutes
GSK is Advancing a Revolutionary Dual HIV Therapy
Gilead has long been the leader in HIV treatments, but GlaxoSmithKline's CEO revealed to the…
01/09/2016 - 3 minutes
GSK Pioneers Money Back Guarantee for Biotech Treatments
The second-ever gene therapy to get European approval finally has a price tag. It will…
16/08/2016 - 3 minutes
Google and GSK invest €630M to create a new Bioelectronics Champion
GSK and Verily Life Sciences are creating a new company together, Galvani Bioelectronics. Along with…
02/08/2016 - 3 minutes
GSK teams up with US Money to found new Biotech
GSK and Avalon Ventures are having success with the Biotechs created under their collaboration. Sitari Pharmaceuticals…
26/05/2016 - 2 minutes
GSK goes to phase II with German Antibody for Inflammatory Diseases
GSK has started a phase II trial for inflammatory hand osteoarthritis, with a candidate originally from…
19/04/2016 - 2 minutes
